Sayana Press
PATH
Solution Overview & Benefits
Sayana Press is a self-administered injectable contraceptive that provides up to three months of protection against pregnancy. It combines a prefilled syringe with the hormone progestin in a user-friendly device, making it accessible for women to use at home or in community settings without needing a healthcare professional for administration. This makes it particularly beneficial for improving contraceptive access in remote and low-resource areas.
History & Development
PATHS's mission is to advance health equity through innovation and partnerships.
PATH developed an ID adapter in partnership with SID Technologies LLC, advancing it forward from the initial concept stage through the manufacture of clinic-ready devices.
As part of this effort, we modified and tested successive design prototypes, incorporating feedback from health care workers in the United States and India.
The design was transferred to commercial partner West Pharmaceutical Services, Inc., which is working with a syringe manufacturer (Helm Medical) on regulatory clearance, manufacturing, and distribution.
Clinical trials and pilot studies have demonstrated safety, efficacy, usability, and health care worker preference for the ID adapter for fIPV, and WHO has purchased a supply of 4 million devices for use by countries interested in introducing fractional dose delivery.
Availability
- Publicly available: yes
- Countries where available: Worldwide
- Price range (USD): Contact supplier for quote
Similar solutions...
Get in Touch!
Get in touch with us by filling out the form or emailing us at contact@techxlab.org.
